Lumenis

Minimally Invasive Laser Technologies

Health Tech & Life Sciences
Acquired by Baring Private Equity Asia on Feb 2020

Company Overview

Snapshot

Founded in December 1991 by Dr. Shimon Eckhouse, Lumenis operates with over 1,000 employees. The company has raised $77.51 million across four funding rounds and was acquired by Baring Private Equity Asia in February 2020.

Business overview

Lumenis develops and commercializes minimally invasive clinical solutions for the surgical, ophthalmologic, and aesthetic markets. The company leverages energy-based technologies, including laser, intense pulsed light, and radio frequency, to create solutions for previously untreatable conditions and enhance existing treatment methods across its operational sectors. Lumenis operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics.

Strategic signal

In March 2026, Lumenis unveiled triLIFT 2.0, introducing advancements in dynamic muscle stimulation for face and body treatments. This launch signals the company's continued innovation in aesthetic medical devices, demonstrating a commitment to enhancing its product portfolio with cutting-edge technologies and maintaining its competitive edge in the beauty and wellness market.

Company Intelligence Q&A

What was a significant recent product launch by Lumenis?
In March 2026, Lumenis unveiled triLIFT 2.0, a new platform introducing dynamic muscle stimulation for face and body treatments, showcasing the company's continued innovation in aesthetic medical devices.
When was Lumenis acquired by Baring Private Equity Asia?
Lumenis was acquired by Baring Private Equity Asia in February 2020.
What award did Lumenis' triLift receive in May 2024?
In May 2024, Lumenis' triLift was awarded "Best New Dermatology Technology Solution" in the 8th Annual MedTech Breakthrough Awards Program.
What new hair loss treatment did Lumenis introduce in June 2024?
In June 2024, Lumenis introduced FoLix, the first FDA-cleared proprietary fractional laser for hair loss treatment, expanding its offerings in aesthetic medical solutions.
When did Boston Scientific complete the acquisition of Lumenis' surgical division?
Boston Scientific completed the acquisition of Lumenis' surgical division for $1 billion in September 2021.

External links